MapLight Therapeutics, Inc. (MPLT) stock
MPLTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$5.94−0.48 (-7.48%)
Close on Nov 20, 2026Market cap $275.48MP/E –Yield –
MapLight Therapeutics free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
MapLight Therapeutics's free cash flow for the twelve months ending Jun 30, 2026 was -$175.12M. For fiscal 2025 it was -$138.61M.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$138.61M | – |
| FY2024 | Dec 31, 2024 | -$79.59M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$44.89M | – |
| Q1 FY2026 | Mar 31, 2026 | -$51.20M | – |
| Q4 FY2025 | Dec 31, 2025 | -$47.21M | – |
| Q3 FY2025 | Sep 30, 2025 | -$31.82M | – |
| Q4 FY2024 | Dec 31, 2024 | -$21.59M | – |
See a number that looks wrong?